Sequential administration of chemotherapy followed by radioimmunotherapy with Iodine-131-Tositumomab in untreated non-Hodgkin's lymphoma (NHL)

被引：0
|
作者：
Kostakoglu, L
Goldsmith, SJ
Vallabhajosula, S
Coleman, M
Morris, A
Link, BK
Kaminski, MS
Nadeau, K
Valente, N
Leonard, JP
机构：
[1] New York Presbyterian Hosp, Weill Cornell Med Ctr, New York, NY USA
[2] Corixa Corp, Redwood City, CA USA
[3] Univ Iowa, Ctr Canc, Iowa City, IA 52242 USA
[4] Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 2001年 / 28卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OS78
引用
收藏
页码：981 / 981
页数：1
相关论文
共 50 条
  • [31] Safety and Efficacy of I(131) Tositumomab in the Treatment of non-Hodgkin's Lymphoma
    Illidge, Tim
    Ivanov, Andrei
    Du, Yong
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 621 - 631
  • [32] Iodine I 131 tositumomab for patients with transformed low-grade non-Hodgkin's lymphoma (NHL): Overall clinical trial experience.
    Zelenetz, AD
    Vose, JM
    Knox, S
    Magnuson, DE
    Kroll, S
    Tidmarsh, G
    Kaminski, MS
    BLOOD, 1999, 94 (10) : 632A - 632A
  • [33] Bexxar - Tositumomab and iodine I 131 tositumoma - Glaxosmithkline/Corixa - New treatment for non-Hodgkin's lymphoma
    不详
    FORMULARY, 2003, 38 (08) : 455 - 456
  • [34] Results of a randomized study of Bexxar™ (tositumomab and iodine I 131 tositumomab) vs. unlabeled tositumomab in patients with relapsed or refractory low-grade or transformed non-Hodgkin's lymphoma (NHL).
    Davis, TA
    Kaminski, MS
    Leonard, JP
    Gregory, SA
    Wahl, R
    Hsu, FJ
    Wilkinson, M
    Frankel, SR
    Serafini, A
    Zelenetz, AD
    Kroll, S
    Coleman, M
    Levy, R
    Knox, SJ
    BLOOD, 2001, 98 (11) : 843A - 843A
  • [35] Radioimmunotherapy of non-Hodgkin's lymphoma
    Britton, KE
    JOURNAL OF NUCLEAR MEDICINE, 2004, 45 (05) : 924 - 925
  • [36] Radioimmunotherapy for non-Hodgkin's lymphoma
    Friedberg, JW
    CLINICAL CANCER RESEARCH, 2004, 10 (23) : 7789 - 7791
  • [37] Radioimmunotherapy for Non-Hodgkin's Lymphoma
    Rao, Arati V.
    Akabani, Gamal
    Rizzieri, David A.
    CLINICAL MEDICINE & RESEARCH, 2005, 3 (03) : 157 - 165
  • [38] Radioimmunotherapy for non-Hodgkin's lymphoma
    Emmanouilides, C
    SEMINARS IN ONCOLOGY, 2003, 30 (04) : 531 - 544
  • [39] Re-treatment with Tositumomab and Iodine I131 Tositumomab (the BEXXAR® therapeutic regimen) in patients with non-Hodgkin's lymphoma (NHL) with a previous response to the BEXXAR therapeutic regimen.
    Kaminski, MS
    Knox, SJ
    Radford, J
    Gregory, SA
    Leonard, JP
    BLOOD, 2003, 102 (11) : 407A - 407A
  • [40] Efficacy and safety of Bexxar® (tositumomab and iodine I 131 tositumomab) in obese patients with low-grade non-Hodgkin's lymphoma.
    Wahl, R
    Goldsmith, SJ
    Zasadny, KR
    Alavi, A
    Divgi, C
    Hankins, J
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 415P - 415P
12345